473 related articles for article (PubMed ID: 16336212)
1. Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle.
Wang Y; Yoshioka K; Azam MA; Takuwa N; Sakurada S; Kayaba Y; Sugimoto N; Inoki I; Kimura T; Kuwaki T; Takuwa Y
Biochem J; 2006 Mar; 394(Pt 3):581-92. PubMed ID: 16336212
[TBL] [Abstract][Full Text] [Related]
2. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
[TBL] [Abstract][Full Text] [Related]
3. Ca2+-independent, inhibitory effects of cyclic adenosine 5'-monophosphate on Ca2+ regulation of phosphoinositide 3-kinase C2alpha, Rho, and myosin phosphatase in vascular smooth muscle.
Azam MA; Yoshioka K; Ohkura S; Takuwa N; Sugimoto N; Sato K; Takuwa Y
J Pharmacol Exp Ther; 2007 Feb; 320(2):907-16. PubMed ID: 17110524
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Ca2+-dependent activation of phosphoinositide 3-kinase class IIα isoform-Rho axis in blood vessels of spontaneously hypertensive rats.
Seok YM; Azam MA; Okamoto Y; Sato A; Yoshioka K; Maeda M; Kim I; Takuwa Y
Hypertension; 2010 Nov; 56(5):934-41. PubMed ID: 20921425
[TBL] [Abstract][Full Text] [Related]
5. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
[TBL] [Abstract][Full Text] [Related]
6. Sevoflurane and isoflurane inhibit KCl-induced Class II phosphoinositide 3-kinase α subunit mediated vasoconstriction in rat aorta.
Yang S; Wu Q; Huang S; Wang Z; Qi F
BMC Anesthesiol; 2016 Aug; 16(1):63. PubMed ID: 27538808
[TBL] [Abstract][Full Text] [Related]
7. Class II phosphatidylinositol 3-kinase α and β isoforms are required for vascular smooth muscle Rho activation, contraction and blood pressure regulation in mice.
Islam S; Yoshioka K; Aki S; Ishimaru K; Yamada H; Takuwa N; Takuwa Y
J Physiol Sci; 2020 Mar; 70(1):18. PubMed ID: 32192434
[TBL] [Abstract][Full Text] [Related]
8. Class II PI3Ks α and β Are Required for Rho-Dependent Uterine Smooth Muscle Contraction and Parturition in Mice.
Sarker MAK; Aki S; Yoshioka K; Kuno K; Okamoto Y; Ishimaru K; Takuwa N; Takuwa Y
Endocrinology; 2019 Jan; 160(1):235-248. PubMed ID: 30476019
[TBL] [Abstract][Full Text] [Related]
9. A role for Rho-kinase in Ca-independent contractions induced by phorbol-12,13-dibutyrate.
Baek I; Jeon SB; Kim J; Seok YM; Song MJ; Chae SC; Jun JE; Park WH; Kim IK
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):256-61. PubMed ID: 18986333
[TBL] [Abstract][Full Text] [Related]
10. Smooth muscle contraction by small GTPase Rho.
Kawano Y; Yoshimura T; Kaibuchi K
Nagoya J Med Sci; 2002 May; 65(1-2):1-8. PubMed ID: 12083286
[TBL] [Abstract][Full Text] [Related]
11. Signaling pathways mediating gastrointestinal smooth muscle contraction and MLC20 phosphorylation by motilin receptors.
Huang J; Zhou H; Mahavadi S; Sriwai W; Lyall V; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G23-31. PubMed ID: 15591586
[TBL] [Abstract][Full Text] [Related]
12. Gi-coupled receptors mediate phosphorylation of CPI-17 and MLC20 via preferential activation of the PI3K/ILK pathway.
Huang J; Mahavadi S; Sriwai W; Hu W; Murthy KS
Biochem J; 2006 May; 396(1):193-200. PubMed ID: 16472257
[TBL] [Abstract][Full Text] [Related]
13. Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells.
Woodsome TP; Polzin A; Kitazawa K; Eto M; Kitazawa T
J Cell Sci; 2006 May; 119(Pt 9):1769-80. PubMed ID: 16608882
[TBL] [Abstract][Full Text] [Related]
14. Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation.
Qi F; Ogawa K; Tokinaga Y; Uematsu N; Minonishi T; Hatano Y
Anesth Analg; 2009 Aug; 109(2):412-7. PubMed ID: 19608811
[TBL] [Abstract][Full Text] [Related]
15. Rho-associated kinase plays a role in rabbit urethral smooth muscle contraction, but not via enhanced myosin light chain phosphorylation.
Walsh MP; Thornbury K; Cole WC; Sergeant G; Hollywood M; McHale N
Am J Physiol Renal Physiol; 2011 Jan; 300(1):F73-85. PubMed ID: 20861082
[TBL] [Abstract][Full Text] [Related]
16. Integrin-linked kinase is responsible for Ca2+-independent myosin diphosphorylation and contraction of vascular smooth muscle.
Wilson DP; Sutherland C; Borman MA; Deng JT; Macdonald JA; Walsh MP
Biochem J; 2005 Dec; 392(Pt 3):641-8. PubMed ID: 16201970
[TBL] [Abstract][Full Text] [Related]
17. Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.
Dimopoulos GJ; Semba S; Kitazawa K; Eto M; Kitazawa T
Circ Res; 2007 Jan; 100(1):121-9. PubMed ID: 17158339
[TBL] [Abstract][Full Text] [Related]
18. EphA4-mediated Rho activation via Vsm-RhoGEF expressed specifically in vascular smooth muscle cells.
Ogita H; Kunimoto S; Kamioka Y; Sawa H; Masuda M; Mochizuki N
Circ Res; 2003 Jul; 93(1):23-31. PubMed ID: 12775584
[TBL] [Abstract][Full Text] [Related]
19. Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway.
Murthy KS; Zhou H; Grider JR; Brautigan DL; Eto M; Makhlouf GM
Biochem J; 2003 Aug; 374(Pt 1):145-55. PubMed ID: 12733988
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aorta.
Shimomura E; Shiraishi M; Iwanaga T; Seto M; Sasaki Y; Ikeda M; Ito K
Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):414-22. PubMed ID: 15459803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
